CryoTherapeutics Announces First Patient Treated in ICECAP Clinical Trial Evaluating Localized Cryotherapy for Coronary Artery Disease

Contributed by: Business Wire

Logo

Tags

Cardiology

Radiology

Health

Artificial Intelligence

Medical Devices

Health Technology

Technology

Clinical Trials

ICECAP Clinical Trial

More Like This

CryoTherapeutics partners with SpectraWAVE and CRF to Launch ICECAP: A First-of-its-Kind Clinical Study Targeting Non-Obstructive High-Risk Coronary Plaques with Cryotherapy and Advanced Intravascular Imaging

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems

PR Newswire associated0

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation

PR Newswire associated0

Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership